Document:

exv10w16

Exhibit 10.16

/*[CONFIDENTIAL TREATMENT REQUESTED]*/ INDICATES MATERIAL THAT HAS BEEN OMITTED AND

FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS

BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406

PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

PAYMENT AGREEMENT

This PAYMENT AGREEMENT (together with any Exhibits hereto, this “Agreement”) is entered into
as of July 28, 2010 by and between Redpipe Networks, Inc., a California corporation (“Redpipe”),
and SiGe Semiconductor, Inc., a Delaware corporation (“Supplier”).

In consideration of the mutual covenants contained herein, and for other good and valuable
consideration, the receipt and adequacy of which are hereby acknowledged, Supplier and Redpipe
agree as follows:

1. Payment Schedule. Subject to the terms and conditions hereof, Supplier shall pay
Redpipe the fixed dollar amount set forth in table 1 of Exhibit A (“Exhibit A”) for each unit of
the Supplier products set forth in table 1 of Exhibit A (“Products”) sold to customers of Supplier
(“Customers”).

2. Reports; Invoices. Within fifteen (15) business days of the end of each month,
Supplier will provide Redpipe with a report specifying the actual amount owed to Redpipe by
Supplier hereunder (“Report”). Each Report must indicate the number of units of Products, by part
number, shipped to each end Customer in the month just closed, including the purchase order number,
invoice number, and Customer order information where available. Supplier will supply documentation
upon request to verify purchase orders, invoices & acknowledgements for actual shipment of
Products. Redpipe may, at its own expense, audit the books and records of Supplier and those in
its supply chain, to the extent not prohibited by vendor agreements, in order to ascertain that
Reports are in accordance herewith. Upon receipt of the Report, Redpipe will issue an invoice to
Supplier (“Invoice”). Terms for Invoices are net forty five (45) days from invoice receipt and
acceptance. All late payments shall be subject to a late payment fee calculated at the rate of one
and half percent (1.5%) per month or the maximum amount allowable by law, whichever is less.

3. Termination. The initial term of this Agreement shall commence on the Effective Date
for a term ending on December 31 following the third anniversary of the date hereof, and shall be
renewed automatically for additional one (1) year periods, provided that no written notice is given
by one party to the other of its intent to terminate this Agreement thirty (30) days prior to the
expiration or any renewal thereof. No party in breach of this Agreement shall have the right to
terminate. This Agreement, including the dollar amount set forth in table 1 of Exhibit A, shall
continue to apply to all existing designs of Products. Either party may terminate this Agreement
based on the material breach of the other party, provided that the terminating party is not
themselves in breach and provided further that the party alleged to be in material breach receives
thirty (30) days written notice stating the cause and an additional thirty (30) days to cure.

4. Confidentiality. The terms and conditions of this Agreement, including its existence
and all information provided in connection with it (including reports, etc.), shall be treated as
Confidential Information under the relevant Nondisclosure Agreements between the parties and shall
not be disclosed to any third party without the consent of the other party. In the event that
either party is requested by any regulatory body (including, without limitation, any rule,
regulation or policy statement of any national securities exchange, market or automated quotation
system on which any of the parties’ securities are or shall be listed or quoted) or by legal
process to disclose any Confidential Information concerning this Agreement, such party (the
“Disclosing Party”) shall provide the other party (the “Non-Disclosing Party”) with prompt notice
and shall take all commercially reasonable actions to, (i) seek an appropriate
confidential treatment, protective order or other remedy, or (ii) resist or narrow the scope of
such request or legal process.

5. Notices. All notices and other communications among the parties shall be in writing and
shall be deemed to have been duly given when (a) delivered in person, or (b) five days after
posting in the United States mail having been sent registered or certified mail return receipt
requested, (c) delivered by FedEx or other nationally recognized overnight delivery service, or (d)
delivered by telecopy and promptly confirmed by delivery in person or post as aforesaid in each
case, with postage prepaid, addressed as follows:

	 	 	 	 	 

	 	 	If to Redpipe, to:
	 

	 	 
	 	Redpipe Networks, Inc.
	 

	 	 	 	2875 Michelle Drive, Suite 100
	 

	 	 	 	Irvine, California 92606
	 

	 	 	 	Attn:   General Counsel
	 
	 	 	 	 
	 	 	If to Supplier, to:
	 

	 	 	 	SiGe Semiconductor, Inc.
	 

	 	 	 	200 Brickstone Square, Suite 203
	 

	 	 	 	Andover, Massachusetts 01810
	 

	 	 	 	Attn:   President and Chief Executive Officer

6. Miscellaneous. This Agreement shall not be construed as creating a partnership, joint
venture, franchise, agency or other such relationship. The parties agree that this Agreement
represents a non-exclusive relationship and does not limit the ability of either party to
participate in other similar relationships with other third parties. This Agreement will be
interpreted under California law and the parties consent to the exclusive jurisdiction and venue of
the state and federal courts located in Orange County, California

/*[CONFIDENTIAL TREATMENT REQUESTED]*/ PROPRIETARY AND CONFIDENTIAL

 

 

to adjudicate any and all disputes arising under this Agreement. The captions in this Agreement are
for convenience only and shall not be considered a part of or affect the construction or
interpretation of any provision of this Agreement. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which together shall constitute
one and the same instrument. This Agreement constitutes the full and final understanding of the
parties with respect to the subject matter hereof. This Agreement merges and supersedes any and
all other agreements and representations, written or oral, relating to that subject matter. Any
waiver of the requirements in this Agreement must be in writing and should not in any way be deemed
a waiver to enforce any other requirements or provisions of this Agreement. Section 3 and 5 shall
survive termination of this Agreement. Unless the context of this Agreement otherwise requires,
words of any gender include each other gender; words using the singular or plural number also
include the plural or singular number, respectively; and the word “or” shall be disjunctive but not
exclusive. The language used in this Agreement shall be deemed to be the language chosen by the
parties to express their mutual intent and no rule of strict construction shall be applied against
any party. Whenever this Agreement refers to a number of days, such number shall refer to calendar
days.

SiGe Semiconductor, Inc.

			
	By:	 	/s/ Sohail A. Khan
 

			
	Name:	 	Sohail A. Khan
 

			
	Title:	 	President and Chief Executive Officer
 

Redpipe Networks, Inc.

			
	By:	 	/s/ Steven Terronez
 

			
	Name:	 	Steven Terronez
 

			
	Title:	 	 
 

2

/*[CONFIDENTIAL TREATMENT REQUESTED]*/ PROPRIETARY AND CONFIDENTIAL

 

EXHIBIT A

Table 1

	 	 	 	 	 	 	 	 

	 	Supplier Products
	 	 	 	Q310-Q213	 	 
	 	/*[CONFIDENTIAL TREATMENT REQUESTED]*/
	 	 	$/*[CONFIDENTIAL TREATMENT REQUESTED]*/	 
	 	/*[CONFIDENTIAL TREATMENT REQUESTED]*/
	 	 	$/*[CONFIDENTIAL TREATMENT REQUESTED]*/	 
	 	/*[CONFIDENTIAL TREATMENT REQUESTED]*/
	 	 	$/*[CONFIDENTIAL TREATMENT REQUESTED]*/	 
	 	/*[CONFIDENTIAL TREATMENT REQUESTED]*/
	 	 	$/*[CONFIDENTIAL TREATMENT REQUESTED]*/	 
	 

3

/*[CONFIDENTIAL TREATMENT REQUESTED]*/ PROPRIETARY AND CONFIDENTIALexv10w20

Exhibit 10.20

AMENDMENT AND WAIVER

March 15, 2011

     This Amendment and Waiver (the “Agreement”) is by and among (a) SiGe Semiconductor,
Inc., a Delaware corporation (the “Company”), and (b) the Investors (as defined in the
Investor Rights Agreement (as defined below)) who hold a majority in interest of the Registrable
Securities (as defined in the Investor Rights Agreement) and the Preferred Registrable Securities
(as defined in the Investor Rights Agreement).

     WHEREAS, the Company, the undersigned Investors and certain other parties are parties to that
certain Amended and Restated Investor Rights Agreement dated as of May 8, 2007 (the “Investor
Rights Agreement”);

     WHEREAS, the Company desires to amend the defined term “Reserved Employee Shares” set forth in
the Investor Rights Agreement by increasing the number of shares of Common Stock (as defined in the
Investor Rights Agreement) that are reserved for issuance under the New Plan (as defined in the
Investor Rights Agreement);

     WHEREAS, in connection with such increase to the number of Reserved Employee Shares, the
Company desires to amend the first sentence of Section 12(a)(xvii) of the Investor Rights Agreement
and to obtain a waiver with respect to any non-compliance thereof occurring on or before the date
hereof;

     WHEREAS, Sections 12(a) and 16(e)(i) of the Investor Rights Agreement provide that any rights
of holders of Registrable Securities may be waived by an instrument in writing executed and
delivered by the holders of a majority in interest of the Registrable Securities or the holders of
a majority in interest of the Preferred Registrable Securities, respectfully;

     WHEREAS, Section 16(e)(ii) of the Investor Rights Agreement provides that the Investor Rights
Agreement may be amended only by the written consent of the Company and holders of a majority in
interest of the Preferred Registrable Securities; and

     WHEREAS, the undersigned constitute Investors who hold at least a majority in interest of the
Preferred Registrable Securities.

     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the Company and the undersigned agree as follows:

     1. Pursuant to Section 16(e)(ii) of the Investor Rights Agreement, the first sentence of
Section 12(a)(xvii) of the Investor Rights Agreement is hereby deleted in its entirety and replaced
with the following:

“(xvii) Stock Option Grant Limitations. Notwithstanding that the Board of
Directors and the Stockholders have approved the amendment of the Company’s 2002
Stock Plan (the “New Plan”) to provide for the issuance of up to 29,133,104
shares of Common Stock, (including shares of Common Stock subject to outstanding
options under the New Plan and shares of Common Stock previously issued pursuant to
the New Plan) (the “New Plan Amount”), the Company covenants and agrees to
issue options and restricted stock under the New Plan for only that number of shares
as is equal to (a) the New Plan Amount less (b) that number of shares of Common
Stock (the “Old Plans Amount”) purchasable pursuant to options outstanding under the
Company’s stock plans other than

 

 

Amendment and Waiver — Page 2

the New Plan (collectively, the “Old Plans”) as the Old Plans Amount may be
reduced from time to time based on the expiration or irrevocable cancellation of
options under the Old Plans.”

     2. Pursuant to Sections 12(a) and 16(e)(i) of the Investor Rights Agreement, the undersigned
hereby irrevocably waive, and agree to irrevocably waive, for themselves and all holders of
Registrable Securities, non-compliance of the covenant set forth in the first sentence of Section
12(a)(xvii) of the Investor Rights Agreement with respect to stock option grants made and/or any
issuance of shares of Common Stock upon the exercise of any such options occurring, in each case,
prior to the date hereof.

     3. Pursuant to Section 16(e)(ii) of the Investor Rights Agreement, the definition of Reserved
Employee Shares set forth in Section 1 of the Investor Rights Agreement is hereby deleted in its
entirety and replaced with the following:

““Reserved Employee Shares” shall mean shares of Common Stock reserved by
the Company from time to time for (i) the sale of shares of Common Stock to
employees, consultants, officers or directors of the Company or any Subsidiary or
(ii) the issuance and/or exercise of options to purchase Common Stock granted to
employees, consultants, officers or directors of the Company or any Subsidiary, not
to exceed (in the case of clause (i) and (ii) combined) in the aggregate 29,133,104
shares of Common Stock (appropriately adjusted to reflect stock splits, stock
dividends, combinations, reclassifications, recapitalizations or other similar
events occurring after the date of this Agreement), after May 8, 2007 (it being
understood that the foregoing number of shares of Common Stock reserved includes shares of Common Stock subject to outstanding options under the New Plan (as defined
in Section 12(a)(xvii)) and shares of Common Stock previously issued pursuant to the
New Plan, which options or shares may be reissued under the New Plan following the
termination of any unexercised options outstanding or any repurchase of such shares
previously issued pursuant to the New Plan). The foregoing number of Reserved
Employee Shares may be increased by vote or written consent of a majority of the
members of the Board of Directors.”

     4. This Agreement shall be effective immediately after its duly execution by Investors who
hold a majority in interest of the Preferred Registrable Securities. This Agreement may be
executed in any number of counterparts, each such counterpart shall be deemed an original
instrument, and all such counterparts together shall constitute but one agreement. This Agreement
may be executed and delivered by facsimile or email (.pdf), and upon such delivery the facsimile or
email (.pdf) signature will be deemed to have the same effect as if the original signature had been
delivered. This Agreement shall be governed by, and construed and enforced in accordance with, the
laws of the State of Delaware, without regard to its principles of conflicts of laws.

[SIGNATURE PAGES FOLLOW]

 

 

Signature Page to Amendment and Waiver

     IN WITNESS WHEREOF, the Company and the undersigned have executed this Agreement to be
effective as of the date first written above.

	 	 	 	 	 
	 	COMPANY:

SIGE SEMICONDUCTOR, INC.

 	 
	 	By:  	/s/ Sohail Khan
 	 
	 	Name:  	Sohail Khan 	 
	 	Title:  	CEO 	 
	 

 

 

Signature Page to Amendment and Waiver

     IN WITNESS WHEREOF, the Company and the undersigned have executed this Agreement to be
effective as of the date first written above.

	 	 	 	 	 
	 	PRISM VENTURE PARTNERS IV, L.P.
 	 
	 	By:  	Prism Venture Partners IV, L.L.C.
its General Partner 	 
	 
	 	 	By:  	/s/
Steven J. Benson 	 
	 	 	 	Managing Director 	 
	 	 	 	 
	 
	 	TD CAPITAL GROUP LIMITED

 	 
	 	By:  	/s/ L. M. Dougherty
 	 
	 	Name:  	L. M. Dougherty 	 
	 	Title:  	President 	 
	 
	 	and

 	 
	 	By:  	/s/ R. H. Greene
 	 
	 	Name:  	R. H. Greene 	 
	 	Title:  	Managing Director 	 
	 
	 	EMERGING TECHNOLOGY I, L.P.

 	 
	 	By:  	/s/ William Byun
 	 
	 	Name:  	William Byun 	 
	 	Title:  	General Partner 	 
	 

 

 

Signature Page to Amendment and Waiver

     IN WITNESS WHEREOF, the Company and the undersigned have executed this Agreement to be
effective as of the date first written above.

	 	 	 	 	 
	 	W CAPITAL PARTNERS II, L.P.

 	 
	 	By:  	/s/ Robert J. Migliorino
 	 
	 	Name:  	Robert J. Migliorino 	 
	 	Title:  	Managing Member 	 
	 
	 	RWI VENTURES II, L.P.

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 
	 	RWI VENTURES I, L.P.

 	 
	 	By:  	/s/ Donald A. Lucas
 	 
	 	Name:  	Donald A. Lucas 	 
	 	Title:  	Managing Member 	 
	 
	 	PETER ENGLISH

 	 
	 	By:  	/s/ Peter English
 	 
	 	Name:  	Peter English 	 
	 	Title:  	 	 
	 
	 	ROBERT HUBAND

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 

 

 

Signature Page to Amendment and Waiver

     IN WITNESS WHEREOF, the Company and the undersigned have executed this Agreement to be
effective as of the date first written above.

	 	 	 	 	 
	 	JOHN STEVENSON

 	 
	 	By:  	/s/ John F. Stevenson
 	 
	 	Name:  	John F. Stevenson 	 
	 	Title:  	 	 
	 
	 	COLIN HURMAN

 	 
	 	By:  	/s/ Colin J. Hurman
 	 
	 	Name:  	Colin J. Hurman 	 
	 	Title:  	 	 
	 
	 	SANIBEL TRUST

c/o NUTTER, McCLENNAN & FISH, LLP

 	 
	 	By:  	/s/ Thomas P. Jalkut
 	 
	 	Name:  	Thomas P. Jalkut 	 
	 	Title:  	Trustee 	 
	 
	 	DAVID HUMPHRYS

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 
	 	JAN PETTERSON

 	 
	 	By:  	/s/ Jan Petterson
 	 
	 	Name:  	Jan Petterson 	 
	 	Title:  	Director 	 
	 

 

 

Signature Page to Amendment and Waiver

     IN WITNESS WHEREOF, the Company and the undersigned have executed this Agreement to be
effective as of the date first written above.

	 	 	 	 	 
	 	HUNT VENTURES L.P.

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 
	 	TINA GRIFFIN

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 
	 	AKOLEO SA

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 

 

 

Signature Page to Amendment and Waiver

     IN WITNESS WHEREOF, the Company and the undersigned have executed this Agreement to be
effective as of the date first written above.

	 	 	 	 	 
	 	THE VENGROWTH INVESTMENT FUND INC.

&

THE VENGROWTH II INVESTMENT FUND INC.

&

THE VENGROWTH III INVESTMENT FUND INC.

 	 
	 	By:  	/s/ Michael Cohen
 	 
	 	Name:  	Michael Cohen 	 
	 	Title:  	Managing General Partner 	 
	 
	 	and

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 
	 	GROWTHWORKS CANADIAN FUND LTD.

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]